JP2018108937A5 - - Google Patents

Download PDF

Info

Publication number
JP2018108937A5
JP2018108937A5 JP2016221064A JP2016221064A JP2018108937A5 JP 2018108937 A5 JP2018108937 A5 JP 2018108937A5 JP 2016221064 A JP2016221064 A JP 2016221064A JP 2016221064 A JP2016221064 A JP 2016221064A JP 2018108937 A5 JP2018108937 A5 JP 2018108937A5
Authority
JP
Japan
Prior art keywords
optionally substituted
hydrogen
substituted alkyl
optionally
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016221064A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018108937A (ja
JP6978758B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2016221064A priority Critical patent/JP6978758B2/ja
Priority claimed from JP2016221064A external-priority patent/JP6978758B2/ja
Priority to US15/809,845 priority patent/US10392400B2/en
Publication of JP2018108937A publication Critical patent/JP2018108937A/ja
Priority to US16/459,120 priority patent/US10844073B2/en
Publication of JP2018108937A5 publication Critical patent/JP2018108937A5/ja
Application granted granted Critical
Publication of JP6978758B2 publication Critical patent/JP6978758B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016221064A 2016-11-11 2016-11-11 パラジウム媒介ケトール化 Active JP6978758B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2016221064A JP6978758B2 (ja) 2016-11-11 2016-11-11 パラジウム媒介ケトール化
US15/809,845 US10392400B2 (en) 2016-11-11 2017-11-10 Palladium-mediated ketolization
US16/459,120 US10844073B2 (en) 2016-11-11 2019-07-01 Palladium-mediated ketolization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016221064A JP6978758B2 (ja) 2016-11-11 2016-11-11 パラジウム媒介ケトール化

Publications (3)

Publication Number Publication Date
JP2018108937A JP2018108937A (ja) 2018-07-12
JP2018108937A5 true JP2018108937A5 (https=) 2019-12-26
JP6978758B2 JP6978758B2 (ja) 2021-12-08

Family

ID=62240368

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016221064A Active JP6978758B2 (ja) 2016-11-11 2016-11-11 パラジウム媒介ケトール化

Country Status (2)

Country Link
US (2) US10392400B2 (https=)
JP (1) JP6978758B2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
ES2931533T3 (es) 2017-04-05 2022-12-30 Harvard College Compuesto macrocíclico y usos del mismo
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
CN111566113B (zh) 2017-11-15 2024-01-09 哈佛大学的校长及成员们 大环化合物及其用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
US5426194A (en) 1993-01-19 1995-06-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 1
US5352804A (en) 1993-01-19 1994-10-04 Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 2
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US6214865B1 (en) 1998-06-17 2001-04-10 Eisai Co., Ltd. Macrocyclic analogs and methods of their use and preparation
JP2001305734A (ja) * 2000-04-20 2001-11-02 Fuji Photo Film Co Ltd 光重合性組成物
JP2003261447A (ja) 2002-03-07 2003-09-16 Kyosei Seiyaku Kk 抗腫瘍剤
EP2522663B1 (en) 2004-06-03 2015-04-01 Eisai R&D Management Co., Ltd. Intermediates for the preparation of halichondrin B
EP1831697A4 (en) 2004-12-09 2011-01-26 Eisai R&D Man Co Ltd SEARCH FOR TUBULINISOTYPES IN CANCER THERAPY USING HALICHONDRIN B ANALOG
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
MY153742A (en) 2007-03-07 2015-03-13 Interdigital Tech Corp Method and apparatus for generating and processing a mac-ehs protocol data unit
US20100254996A1 (en) 2007-06-18 2010-10-07 Medimmune, Llc Synergistic treatment of cells that express epha2 and erbb2
RU2489437C2 (ru) 2007-10-03 2013-08-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Промежуточные соединения и способы синтеза аналогов галихондрина в
RU2010118063A (ru) 2007-11-16 2011-12-27 ЭЙСАЙ Ар энд Ди МЕНЕДЖМЕНТ КО., ЛТД. (JP) Новое промежуточное соединение для синтеза аналога галихондрина в и новая реакция десульфонилирования, применяемая для получения промежуточного соединения
CN105801599A (zh) 2008-04-04 2016-07-27 卫材R&D管理有限公司 软海绵素b类似物
WO2011094339A1 (en) 2010-01-26 2011-08-04 Eisai R&D Management Co., Ltd. Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs
WO2012096926A2 (en) 2011-01-10 2012-07-19 President And Fellows Of Harvard College Method for delivering agents into cells using bacterial toxins
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
CN104024237B (zh) 2011-12-16 2016-02-24 阿方拉研究股份有限公司 用于制备3-((2s,5s)-4-亚甲基-5-(3-氧代丙基)四氢呋喃-2-基)丙醇衍生物的方法及其有用的中间体
CN104080793B (zh) 2011-12-29 2017-09-19 阿方拉研究股份有限公司 2‑((2s,3s,4r,5r)‑5‑((s)‑3‑氨基‑2‑羟基丙‑1‑基)‑4‑甲氧基‑3‑(苯磺酰甲基)四氢呋喃‑2‑基)乙醛衍生物以及它们的制备方法
WO2013142999A1 (en) 2012-03-30 2013-10-03 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein
CA2916537C (en) 2013-07-03 2021-07-27 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
EP3689881B1 (en) 2013-11-04 2022-01-12 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b
MX384292B (es) 2013-12-06 2025-03-14 Eisai R&D Man Co Ltd Metodos utiles en la sintesis de analogos de halicondrina b.
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
WO2016038624A1 (en) 2014-09-09 2016-03-17 Cipla Limited "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof"
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
KR102743950B1 (ko) 2015-05-07 2024-12-18 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤라이드의 합성에 유용한 마크로고리화 반응 및 중간체 및 기타 단편
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
ES2931533T3 (es) 2017-04-05 2022-12-30 Harvard College Compuesto macrocíclico y usos del mismo
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise

Similar Documents

Publication Publication Date Title
JP2018108937A5 (https=)
EA021854B1 (ru) Дисахариновая, дифумаровокислая, ди-1-гидрокси-2-нафтойнокислая и монобензойнокислая соли 4-(диметиламино)бутил-2-(4-((2-амино-4-метил-6-(пентиламино)пиримидин-5-ил)метил)фенил)ацетата
CN104402862B (zh) 艾立替尼的制备方法
WO2016012470A1 (en) New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
CA2722016A1 (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
ES2594252T3 (es) Compuesto de quinolona y composición farmacéutica
RU2009110413A (ru) Способ получения производных 3-дигалогенметил-пиразол-4-карбоновой кислоты
JPH0331715B2 (https=)
KR102142797B1 (ko) 피리디닐아미노피리미딘 유도체의 메실레이트 염의 결정질 형태, 그의 제조 방법, 및 그의 용도
JP2010529986A5 (https=)
WO2009125841A1 (ja) 5-メチルウリジンを出発原料とするエチニルチミジン化合物の製造方法
JPH06234741A (ja) 置換4−フエニルピリドン及び4−フエニル−2−アルコキシピリジン
WO2021231335A1 (en) Novel intermediates and synthesis for endochin-like quinolone compounds
WO2013018371A1 (ja) ビアリールエステル誘導体、及びそれを含む医薬
CN105418610A (zh) 一种10-羟基吴茱萸碱类抗肿瘤化合物及其制备方法和应用
US6649767B2 (en) Process for preparing 1,4-dihydropyridine compounds
JP2019523230A (ja) 抗転移性2H‐セレノフェノ[3,2‐h]クロメン、それらの合成、および同薬剤の使用方法
Le Anh et al. Synthesis and Molecular Structure of Dibenzo [4-(α-Thienyl-and α-Pyrrolyl) pyrido] aza-14-crown-4 Ethers
CN101544670A (zh) 一种糖精阿德福韦酯及制备方法
CN108794517B (zh) 一种精氨酸酶抑制剂及其制备方法与用途
Luo et al. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol
JP2010513510A5 (https=)
TWI439463B (zh) 青蒿素之二聚衍生物及其在抗癌治療之應用
Diwischek et al. Cerulenin analogues as inhibitors of efflux pumps in drug‐resistant Candida albicans
CN104829669A (zh) 具有细胞毒活性的2’,5’-双脱氧-5-氟尿嘧啶核苷衍生物、生产方法和应用